KE3739A - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- KE3739A KE3739A KE3739A KE373987A KE3739A KE 3739 A KE3739 A KE 3739A KE 3739 A KE3739 A KE 3739A KE 373987 A KE373987 A KE 373987A KE 3739 A KE3739 A KE 3739A
- Authority
- KE
- Kenya
- Prior art keywords
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8126786 | 1981-09-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
KE3739A true KE3739A (en) | 1987-09-04 |
Family
ID=10524316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KE3739A KE3739A (en) | 1981-09-04 | 1987-07-10 | Pharmaceutical compositions |
Country Status (15)
Country | Link |
---|---|
JP (1) | JPS5865215A (xx) |
AU (1) | AU564018B2 (xx) |
BE (1) | BE894285A (xx) |
CH (1) | CH652304A5 (xx) |
DE (1) | DE3232830C2 (xx) |
FR (1) | FR2512342B1 (xx) |
HK (1) | HK91387A (xx) |
IE (1) | IE54149B1 (xx) |
IT (1) | IT1208432B (xx) |
KE (1) | KE3739A (xx) |
MY (1) | MY8700560A (xx) |
NL (1) | NL193821C (xx) |
SE (1) | SE8205034L (xx) |
SG (1) | SG59387G (xx) |
ZA (1) | ZA826477B (xx) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8516083D0 (en) * | 1985-06-25 | 1985-07-31 | Glaxo Group Ltd | Heterocyclic compounds |
JPH01197444A (ja) * | 1986-03-04 | 1989-08-09 | Bristol Myers Co | 非ステロイド系抗炎症組成物によって生じる消化管損傷に対するβ−アドレナリン作用薬とある種のヒスタミンH↓1−および/またはH↓2−受容体遮断薬との組合せの効果 |
GB2222772B (en) * | 1988-09-20 | 1992-05-13 | Glaxo Group Ltd | Pharmaceutical compositions |
EP1171161A1 (en) * | 1999-04-19 | 2002-01-16 | Richard Weisbart | Treatment of adult rheumatoid arthritis by oral administration of pooled human immunoglobulin and an antacid |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2360306A1 (fr) * | 1976-08-03 | 1978-03-03 | Huguet Georgette | Nouveaux medicaments antalgiques, antiseptiques et anti-inflammatoires |
GB1565966A (en) * | 1976-08-04 | 1980-04-23 | Allen & Hanburys Ltd | Aminoalkyl furan derivatives |
-
1982
- 1982-09-02 BE BE0/208936A patent/BE894285A/fr not_active IP Right Cessation
- 1982-09-03 AU AU87997/82A patent/AU564018B2/en not_active Expired
- 1982-09-03 ZA ZA826477A patent/ZA826477B/xx unknown
- 1982-09-03 FR FR8215042A patent/FR2512342B1/fr not_active Expired
- 1982-09-03 CH CH5245/82A patent/CH652304A5/fr not_active IP Right Cessation
- 1982-09-03 IT IT8249071A patent/IT1208432B/it active
- 1982-09-03 DE DE3232830A patent/DE3232830C2/de not_active Expired - Lifetime
- 1982-09-03 NL NL8203457A patent/NL193821C/nl not_active IP Right Cessation
- 1982-09-03 JP JP57153791A patent/JPS5865215A/ja active Pending
- 1982-09-03 SE SE8205034A patent/SE8205034L/xx unknown
- 1982-09-03 IE IE2152/82A patent/IE54149B1/en not_active IP Right Cessation
-
1987
- 1987-07-10 KE KE3739A patent/KE3739A/xx unknown
- 1987-07-22 SG SG593/87A patent/SG59387G/en unknown
- 1987-12-03 HK HK913/87A patent/HK91387A/xx not_active IP Right Cessation
- 1987-12-30 MY MY560/87A patent/MY8700560A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AU564018B2 (en) | 1987-07-30 |
CH652304A5 (fr) | 1985-11-15 |
SE8205034D0 (sv) | 1982-09-03 |
IE822152L (en) | 1983-03-04 |
SE8205034L (sv) | 1983-03-05 |
SG59387G (en) | 1987-10-23 |
FR2512342B1 (fr) | 1986-09-05 |
IT8249071A0 (it) | 1982-09-03 |
AU8799782A (en) | 1983-03-10 |
NL193821C (nl) | 2000-12-04 |
BE894285A (fr) | 1983-03-02 |
FR2512342A1 (fr) | 1983-03-11 |
MY8700560A (en) | 1987-12-31 |
HK91387A (en) | 1987-12-11 |
DE3232830A1 (de) | 1983-03-24 |
JPS5865215A (ja) | 1983-04-18 |
NL8203457A (nl) | 1983-04-05 |
IT1208432B (it) | 1989-06-12 |
IE54149B1 (en) | 1989-07-05 |
DE3232830C2 (de) | 1994-12-08 |
NL193821B (nl) | 2000-08-01 |
ZA826477B (en) | 1984-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH25637A (en) | Dipyridamole-containing pharmaceutical form | |
GB8326565D0 (en) | Pharmaceutical compositions | |
GB8327612D0 (en) | Pharmaceutical compositions | |
ZA824622B (en) | Pharmaceutical compositions | |
NZ201520A (en) | Substituted aminopyridazines and pharmaceutical compositions | |
ZA825397B (en) | Pharmaceutical compositions | |
ZA81136B (en) | Pharmaceutical compositions | |
ZA822856B (en) | Pharmaceutical compositions | |
GB2118176B (en) | Pharmaceutical compositions | |
GB2117766B (en) | Pharmaceutical compositions | |
GB8324133D0 (en) | Pharmaceutical compositions | |
ZA82652B (en) | Pharmaceutical compositions | |
GB2072504B (en) | Pharmaceutical compositions | |
ZA815700B (en) | Pharmaceutical compositions | |
GB8313814D0 (en) | Pharmaceutical compositions | |
DE3377696D1 (en) | Pharmaceutical compositions | |
GB2114001B (en) | Nasel pharmaceutical compositions | |
PT73952A (en) | Pharmaceutical compositions | |
ZA826479B (en) | Pharmaceutical compositions | |
HK91387A (en) | Pharmaceutical compositions | |
GB8305028D0 (en) | Pharmaceutical compositions | |
GB8330810D0 (en) | Pharmaceutical compositions | |
GB8314736D0 (en) | Pharmaceutical compositions | |
ZA82186B (en) | Pharmaceutical compositions | |
DE3264222D1 (en) | New pharmaceutical compositions containing guanidinopyrimidines |